BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32828867)

  • 1. miR-451a suppresses the development of breast cancer via targeted inhibition of CCND2.
    Zhang H; Chen P; Yang J
    Mol Cell Probes; 2020 Dec; 54():101651. PubMed ID: 32828867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway.
    Sun WM; Tao W; Li JC; Zhu DM; Miao Y
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10422-10432. PubMed ID: 31841196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).
    He X; Chen SY; Yang Z; Zhang J; Wang W; Liu MY; Niu Y; Wei XM; Li HM; Hu WN; Sun GG
    J Exp Clin Cancer Res; 2018 Sep; 37(1):230. PubMed ID: 30227870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-144 suppresses proliferation, invasion, and migration of breast cancer cells through inhibiting CEP55.
    Yin Y; Cai J; Meng F; Sui C; Jiang Y
    Cancer Biol Ther; 2018 Apr; 19(4):306-315. PubMed ID: 29561704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-451a suppresses cell proliferation, metastasis and EMT via targeting YWHAZ in hepatocellular carcinoma.
    Wei GY; Hu M; Zhao L; Guo WS
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5158-5167. PubMed ID: 31298411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA LINC00473 indicates a poor prognosis of breast cancer and accelerates tumor carcinogenesis by competing endogenous sponging miR-497.
    Bai J; Zhao WY; Li WJ; Ying ZW; Jiang DQ
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3410-3420. PubMed ID: 31081095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-182-5p Knockdown Targeting PTEN Inhibits Cell Proliferation and Invasion of Breast Cancer Cells.
    Zhao YS; Yang WC; Xin HW; Han JX; Ma SG
    Yonsei Med J; 2019 Feb; 60(2):148-157. PubMed ID: 30666836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circ-UBR1 facilitates proliferation, metastasis, and inhibits apoptosis in breast cancer by regulating the miR-1299/CCND1 axis.
    Zhang L; Sun D; Zhang J; Tian Y
    Life Sci; 2021 Feb; 266():118829. PubMed ID: 33259864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-646 suppresses proliferation and metastasis of non-small cell lung cancer by repressing FGF2 and CCND2.
    Wang J; Shu H; Guo S
    Cancer Med; 2020 Jun; 9(12):4360-4370. PubMed ID: 32347652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR‑135b‑5p enhances the sensitivity of HER‑2 positive breast cancer to trastuzumab via binding to cyclin D2.
    Li Z; Qin Y; Chen P; Luo Q; Shi H; Jiang X
    Int J Mol Med; 2020 Oct; 46(4):1514-1524. PubMed ID: 32700749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
    Fei X; Zhang P; Pan Y; Liu Y
    Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-promoting properties of miR-8084 in breast cancer through enhancing proliferation, suppressing apoptosis and inducing epithelial-mesenchymal transition.
    Gao Y; Ma H; Gao C; Lv Y; Chen X; Xu R; Sun M; Liu X; Lu X; Pei X; Li P
    J Transl Med; 2018 Feb; 16(1):38. PubMed ID: 29471858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial infarction associated transcript (MIAT) promotes papillary thyroid cancer progression via sponging miR-212.
    Wang R; Zhao L; Ji L; Bai L; Wen Q
    Biomed Pharmacother; 2019 Oct; 118():109298. PubMed ID: 31404776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway.
    Riquelme I; Tapia O; Leal P; Sandoval A; Varga MG; Letelier P; Buchegger K; Bizama C; Espinoza JA; Peek RM; Araya JC; Roa JC
    Cell Oncol (Dordr); 2016 Feb; 39(1):23-33. PubMed ID: 26458815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA GAS8-AS1 suppresses papillary thyroid carcinoma cell growth through the miR-135b-5p/CCND2 axis.
    Chen N; Yin D; Lun B; Guo X
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30429236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA HOTAIR Regulates CCND1 and CCND2 Expression by Sponging miR-206 in Ovarian Cancer.
    Chang L; Guo R; Yuan Z; Shi H; Zhang D
    Cell Physiol Biochem; 2018; 49(4):1289-1303. PubMed ID: 30205383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
    Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
    Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    PLoS One; 2015; 10(9):e0138560. PubMed ID: 26393798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC01016 promotes the malignant phenotype of endometrial cancer cells by regulating the miR-302a-3p/miR-3130-3p/NFYA/SATB1 axis.
    Pan X; Li D; Huo J; Kong F; Yang H; Ma X
    Cell Death Dis; 2018 Feb; 9(3):303. PubMed ID: 29467441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-665 expression predicts poor survival and promotes tumor metastasis by targeting NR4A3 in breast cancer.
    Zhao XG; Hu JY; Tang J; Yi W; Zhang MY; Deng R; Mai SJ; Weng NQ; Wang RQ; Liu J; Zhang HZ; He JH; Wang HY
    Cell Death Dis; 2019 Jun; 10(7):479. PubMed ID: 31209222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.